The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 26, 2015

Filed:

Sep. 25, 2009
Applicants:

Roland Pfau, Biberach, DE;

Kirsten Arndt, Ravensburg, DE;

Henri Doods, Warthausen, NL;

Norbert Hauel, Schemmerhofen, DE;

Klaus Klinder, Oggelshausen, DE;

Raimund Kuelzer, Mittelbiberach, DE;

Juergen Mack, Biberach, DE;

Dirk Stenkamp, Biberach, DE;

Inventors:

Roland Pfau, Biberach, DE;

Kirsten Arndt, Ravensburg, DE;

Henri Doods, Warthausen, NL;

Norbert Hauel, Schemmerhofen, DE;

Klaus Klinder, Oggelshausen, DE;

Raimund Kuelzer, Mittelbiberach, DE;

Juergen Mack, Biberach, DE;

Dirk Stenkamp, Biberach, DE;

Assignee:

Orexo AB, Uppsala, SE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); C07D 401/00 (2006.01); C07D 221/02 (2006.01); C07D 471/02 (2006.01); C07D 235/30 (2006.01); C07D 263/58 (2006.01); C07D 277/82 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 235/30 (2013.01); C07D 263/58 (2013.01); C07D 277/82 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01);
Abstract

There are provided compounds of formula (I), wherein R, R, R, Q, Q, Q, Q, L and A have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation and/or cancer.


Find Patent Forward Citations

Loading…